The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $90,000.00 firm fixed price delivery order to Life Molecular Imaging Limited, a global leader in radiopharmaceuticals. The contract is to provide amyloid doses and tau protein positron emission tomography (PET) imaging services to support NIA's research efforts and mission of understanding aging and extending healthy lifespans. This award is part of a larger $1.9 million...
The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $60,000 firm fixed price delivery order contract to Life Molecular Imaging Limited for amyloid doses. Under this contract, Life Molecular Imaging Limited will provide amyloid doses to support the National Institute on Aging's research efforts. The contract has a period of performance of one year, running from September 15, 2023 through September 14, 2024. Life Molecular Imaging...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD) to Life Molecular Imaging LIMITED, a UK-based manufacturer of radiopharmaceuticals and molecular imaging technologies. The $12,000 contract is for the delivery of FDA-approved radioligand doses to support medical research, specifically the Baltimore Longitudinal Study of Aging, which aims to characterize brain changes and understand aging processes. Life Molecular Imaging...
This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian federal agency, to Life Molecular Imaging LIMITED, a UK-based for-profit manufacturer of radiopharmaceuticals and molecular imaging technologies. The $84,400 contract is for the provision of an amyloid imaging agent, which supports critical medical research, specifically the Baltimore Longitudinal Study of Aging. The contract has no set-aside designation. Life Molecular Imaging LIMITED...
This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Life Molecular Imaging LIMITED, a for-profit manufacturer of goods headquartered in the United Kingdom. The purpose of the $60,000.00 contract is for Life Molecular Imaging LIMITED to provide 40 FDA-approved amyloid positron emission tomography (PET) radioligand doses. The delivery order is part of a larger $1,900,000.00 indefinite delivery vehicle (IDV) contract Life...
This is a Delivery Order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Chesapeake Open MRI, LLC, a for-profit limited liability company. The contract is for Amyloid and Tau PET scans for the Baltimore Longitudinal Study of Aging (BLSA) and has a firm fixed price of $303,680.00. The contract does not have a set-aside designation and has an ultimate completion date of September 14, 2025. The award date is September 15, 2024. The place of performance is Cape St....
The National Institute on Aging (NIA), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded an $852,000 firm fixed price delivery order contract to The Bioteam, Inc. (Bioteam) under the company's Multiple Award Schedule contract vehicle. Bioteam will perform an Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Data Ecosystem Landscape Assessment for NIA through November 15, 2023 from its place of performance...
This is a firm fixed-price federal contract award to Life Molecular Imaging LIMITED, a for-profit organization and manufacturer of goods based in the United Kingdom. The contract, valued at $16,800.00, was awarded by the National Institute of Child Health and Human Development (NICHD) on August 19, 2016 and has an ultimate completion date of December 31, 2016. The contract is for the provision of Florbetaben F18 Injections, which are radiopharmaceuticals used for positron emission tomography...
This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...
This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract, valued at $858,106.08, is for the experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This work supports ongoing NIA research initiatives such as the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and PREVENT-AD studies....